Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study

Sara M. Tolaney*, Hovav Nechushtan, Ilan Gil Ron, Patrick Schöffski, Ahmad Awada, Chris A. Yasenchak, A. Douglas Laird, Bridget O’Keeffe, Geoffrey I. Shapiro, Eric P. Winer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study'. Together they form a unique fingerprint.

Medicine & Life Sciences